KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Teladoc Health (TDOC) Short-term Investments (2016 - 2022)

Teladoc Health's Short-term Investments history spans 8 years, with the latest figure at $2.5 million for Q2 2022.

  • For Q2 2022, Short-term Investments changed 0.04% year-over-year to $2.5 million; the TTM value through Jun 2022 reached $2.5 million, changed 0.04%, while the annual FY2021 figure was $2.5 million, 95.24% down from the prior year.
  • Short-term Investments for Q2 2022 was $2.5 million at Teladoc Health, roughly flat from $2.5 million in the prior quarter.
  • Across five years, Short-term Investments topped out at $54.6 million in Q1 2018 and bottomed at $2.5 million in Q1 2021.
  • The 5-year median for Short-term Investments is $3.1 million (2020), against an average of $18.9 million.
  • The largest annual shift saw Short-term Investments soared 1864.04% in 2020 before it crashed 95.24% in 2021.
  • A 5-year view of Short-term Investments shows it stood at $54.5 million in 2018, then crashed by 95.03% to $2.7 million in 2019, then skyrocketed by 1864.04% to $53.2 million in 2020, then plummeted by 95.24% to $2.5 million in 2021, then increased by 0.08% to $2.5 million in 2022.
  • Per Business Quant, the three most recent readings for TDOC's Short-term Investments are $2.5 million (Q2 2022), $2.5 million (Q1 2022), and $2.5 million (Q4 2021).